title: High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders.
authors.forename: L
authors.initials: L
authors.lastname: Cavanna
authors.forename: G
authors.initials: G
authors.lastname: Sbolli
authors.forename: E
authors.initials: E
authors.lastname: Tanzi
authors.forename: L
authors.initials: L
authors.lastname: Romanò
authors.forename: G
authors.initials: G
authors.lastname: Civardi
authors.forename: E
authors.initials: E
authors.lastname: Buscarini
authors.forename: D
authors.initials: D
authors.lastname: Vallisa
authors.forename: R
authors.initials: R
authors.lastname: Berté
authors.forename: A
authors.initials: A
authors.lastname: Rossi
mesh_terms: D015331:Cohort Studies; D015897:Comorbidity; D016174:Hepacivirus / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008232:Lymphoproliferative Disorders / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D012189:Retrospective Studies; D016036:Seroepidemiologic Studies
chemical_list: D018937:Hepatitis C Antibodies